Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life

Table 3

Beta-blocker and quality of life.

Questionnaire	ANOVA with Bonferroni post hoc
Ocular surface symptoms	Baseline vs after 1 month	After 1 month vs after 3 months
Have you experienced any of the following during the last week:	value	value
(1) Eyes that are sensitive to light?	0.003	0.002
(2) Foreign body sensation?	<0.001	0.880
(3) Painful eye?	<0.001	<0.001
(4) Blurred vision?	0.007	<0.001
(5) Poor vision?	0.208	<0.001
(6) Ocular redness?	<0.001	<0.001
General symptoms
Have you experienced any of the following during the last week:
(7) Breathlessness at rest	0.045	<0.001
(8) Breathlessness after exercise	0.083	<0.001
(9) Fatigue, faintness	0.001	0.059
(10) Slow heart beat	0.321	<0.001
(11) Insomnia	0.038	0.279
(12) Headache	0.251	<0.001
Did you have any problems with your eyes that limited you in performing any of the following during the last week:
(13) Reading?	<0.001	<0.001
(14) Driving at night?	0.001	0.001
(15) Working with a computer?	0.001	<0.001
(16) Watching TV?	0.001	<0.001
Have your eyes felt uncomfortable in any of the following situations during the last week:
(17) Windy conditions ?	<0.001	<0.001
(18) Place or areas with low humidity (very dry)?	<0.001	<0.001
(19) Areas that are air-conditioned ?	<0.001	<0.001
During the last week:
(20) How do you assess the intensity of the ocular surface symptoms?	<0.001	<0.001
(21) Were you satisfied with the treatment?	<0.001	<0.001
(22) How many times did not you instill the eye drop?	0.006	0.001
(23) How was your quality of life related to treatment?	<0.001	<0.001

From [95].